AskVantage

TelyRx Finco

TelyRx Finco is a startup headquartered in Toronto, Canada, founded in 2026. It has raised at least $12.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2026Founded
StartupStage
Toronto, CanadaHeadquarters
PharmaceuticalsIndustry
$12.6m+Raised (SEC filings)
EarlyFunding stage
Pharmaceuticals
See it on the interactive mapBook a Briefing

Funding

TelyRx Finco has raised at least $12.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

TelyRx Finco sits inside the Toronto R&D ecosystem in the Global R&D Labs Directory.

Other startups in Toronto

Related

Questions and answers

What does TelyRx Finco do?

TelyRx Finco is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.

How much has TelyRx Finco raised?

At least $12.6m, according to its Form D filings with the US Securities and Exchange Commission.

Where is TelyRx Finco based?

TelyRx Finco is headquartered in Toronto, Canada.

When was TelyRx Finco founded?

TelyRx Finco was founded in 2026.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.